Latest news with #heartattack
The Sun
an hour ago
- Entertainment
- The Sun
Model dies of heart attack after getting boob job in Turkey & ‘partying with her surgeon night before going under knife'
A SINGER and top model has died of a heart attack after undergoing plastic surgery in Turkey. Ana Barbara Buhr Buldrini, 31, is said to have gone under the knife just a day after she partied with her husband and the surgeon who performed on her. 5 5 Her husband Elgar Miles said the Brazilian - who had 800,000 followers on Instagram - suffered a fatal heart attack after the op. Ana, from Belo Horizonte, had travelled to Turkey with her husband to undergo the extensive liposuction, breast augmentation and rhinoplasty surgeries on May 31. Less than 24 hours after the couple had a night out on the town with the doctor. The surgery was set to take place on Wednesday, June 18, but it was instead performed on Sunday, June 15, at the doctor's request, according to reports. But there were complications and Ana Barbara passed away on June 16. Elgar said: "The doctor assured me that there were no problems and that everything would be fine." According to Ana Barbara's husband, the night before the couple went out partying. And they were accompanied by the doctor who was to perform the procedure. The couple asked the surgeon if it was safe to have the surgery hours after they all spent the night out. But he reportedly assured them that there would be no problems. Elgar also said that at around 11 pm on Sunday the surgery had beenad already been completed and the medical team said that Ana was unconscious but would soon be awake. But he noticed that his wife no longer showed signs of life. Elgar said: "They told me to go to the room, the assistants were acting strangely. "I waited for one hour and 15 minutes to see her. "I went down to the ground floor and a doctor said that her heart was beating slowly, while another said that she was already dead." 5 5 According to Elgar, the Turkish police were called to the hospital and doctors from the clinic were temporarily detained, however, they were released after providing clarification. Ana's family members have accused the doctors of medical negligence. Her brother, Bruno Buhr Buldrini, said: "The doctors rushed the process. What they did was cowardice." Elgar added: "We will transfer her body to Mozambique and seek justice, so that they pay for what they did." Ana Barbara's body is set to be cremated in Maputo on June 21. Warning over cheap Turkey ops CUT-PRICE 'too good to be true' cosmetic ops in Turkey are dangerous and need regulating, warned the UK's Health Secretary. Wes Streeting urged people to research the risks and think twice before flying abroad to get work done. He wants to work with governments of other countries to improve safety. Turkey is top destination for popular surgeries including boob jobs, tummy tucks, butt and facelifts, as it is cheaper. Seven in ten foreign cosmetic ops on Brit patients are done there. But horror stories are common and several UK women have died in recent years from complications. There are particular concerns about the safety of Brazilian butt lifts — known as the most dangerous procedure but growing in popularity. Research from the British Association of Aesthetic Plastic Surgeons found half of those who go abroad for cosmetic ops come to regret it. Mr Streeting said: 'We need to take very seriously medical negligence and malpractice overseas. If the offer looks too good to be true, I suspect it's too good to be true. 'Think very carefully before flying overseas and paying a rock-bottom price, because you may end up paying the consequences for years. The injuries can be life-changing.'
The Sun
an hour ago
- Health
- The Sun
Urgent warning over drug taken by millions – as AstraZeneca accused of ‘misreporting' safety data
MEDICS have raised concerns over a drug taken by millions to prevent heart attacks and strokes, claiming key safety data was "misreported" by its manufacturer AstraZeneca. Anti-clotting pill ticagrelor has been available on the NHS in 2011, after trials appeared to show it could prevent one in five deaths after a heart attack. But an investigation published in the BMJ cast doubt "over the integrity of the clinical trials that underpinned its approval". Ticagrelor is an antiplatelet medicine that prevents blood cells from sticking together and forming dangerous clots. The twice-daily pill is prescribed to patients with acute coronary syndrome who are at greater risk of blood clots due to a history of heart attack, angina or stroke - often in combination with a low dose of aspirin. In the UK, the drug is prescribed around 45,000 times per month on the NHS. Now, experts claim to have uncovered "evidence of serious misreporting" in two clinical trials that were pivotal to the drug's approval in the UK and US. These findings raise "doubts over the approval and decade long use of ticagrelor", sold as Brilique in the UK, the report authors wrote in the BMJ. In response, an AstraZeneca spokesperson told Sun Health: 'We are confident in the integrity of the trials and its evidence in support for Brilique.' Two AstraZeneca studies, known as ONSET/OFFSET and RESPOND, were published in the leading journal Circulation, reporting the drug's effects on platelet function. The ONSET/OFFSET trial involved 123 patients and found that ticagrelor was faster and better at preventing clots than a competitor drug. Similar results were published in RESPOND, which involved 98 patients. Early warning sign of heart attack you may notice in bed But the report authors claimed claimed 'primary endpoint' results in the two key trials - which were pivotal in determining the treatment's effectiveness - were inaccurately reported in Circulation. "We found evidence that the trials were inaccurately reported," they said. "In one instance, AstraZeneca's trial failed to show statistical significance, but was published in a leading cardiology journal as significant." It also said around a quarter of the readings from machines used in the trials were not included in the data sets, the US medicine's regulator, the Food and Drug Administration (FDA) used to approve the drug. In order for ticagrelor to get approved, clinical trials had to prove that it was a better drug than competitors in a phase 3 trial. After phase 3 and drug approval, the FDA and MHRA in the UK, continues monitoring it in phase 4 trials, to see if there are any additional problems with the drug. But the BMJ analysis of two phase 2 trial results found there were instances of patients whose blood "platelet aggregation dramatically increased". This is when blood cells stick together to form clumps, which can lead to blood clots - exactly what the drug aims to prevent. Key facts about ticagrelor Ticagrelor is an antiplatelet medicine that prevents platelets - a type of blood cell - from sticking together and forming a dangerous blood clot. Taking ticagrelor can help prevent blood clots if you have an increased risk of having them because you: Have had a heart attack Have unstable angina Have had a stroke or a transient ischaemic stroke (TIA, or mini-stroke) Ticagrelor is only available on prescription. You'll usually take ticagrelor twice a day and it's often prescribed together with low-dose aspirin at the start of treatment. The main side effects of ticagrelor are getting out of breath and bleeding more easily than normal. You may have nosebleeds, heavier periods, bleeding gums and bruising. According to medicines watchdog the National Institute for Health and Care Excellence (NICE), patients are advised to take the drug twice a day at 90mg for around a year after a heart attack. A lower dose of 60mg, may then be prescribed by doctors for up to a further three years. It may also be taken by those who have suffered a minor stroke or a transient ischaemic attack at 90mg alongside aspirin. Sources: NHS, NICE This is "an improbable effect for an anti-platelet drug" and "suggests an incorrect laboratory reading", the BMJ said. Assessing the readings from platelet machines used at the two trial sites, led by cardiologist Dr Paul Gurbel, investigators also found more than 60 of the 282 readings were not included in datasets submitted to the FDA. "The platelet activity levels not entered were significantly higher than those used in the Circulation papers and FDA datasets," they claimed. "It is unclear whose blood was sampled, and why those measurements did not contribute to data in either trial." The report authors conducted their investigation through interviews with trial investigators and platelet experts and access to the underlying trial data submitted to regulators. They also said that principal investigators involved in ticagrelor trials "were unreachable or declined to be interviewed". "The findings raise even deeper questions over the approval and decade long use of the drug," the authors claimed. Dr Victor Serebruany, an expert in cardiovascular pharmacology at Johns Hopkins University in Maryland, who has been critical of the drug for over a decade said: "It's been obvious for years that there is something wrong with the data. "That the FDA's leadership could look past all these problems- on top of the many problems their own reviewers identified and are now being discovered by The BMJ - is unconscionable. "We all need to know how and why that happened. "If doctors had known what happened in these trials, they would never have started using ticagrelor." But a spokesperson for the Sinai Center for Thrombosis Research and Drug Development, which Dr Gurbel leads, told MailOnline: "Any allegations of any research misconduct in the two studies are baseless and erroneous." Sun Health has also contacted Circulation for comment. The journal did not respond to the BMJ. How to reduce your risk of heart attacks and stroke You can reduce your risk of heart attack and stroke with many of the same methods. Heart attacks and strokes, although affecting different organs of the body, are both what we call cardiovascular events. Both arise from similar underlying conditions, such as atherosclerosis —a buildup of fatty deposits in the arteries. According to the American Heart Association, the risk factors for heart attacks and strokes are largely the same: high blood pressure, high cholesterol, smoking, obesity, physical inactivity and diabetes. Therefore, addressing these risk factors can simultaneously reduce the risk of both conditions. Here are ways you can prevent the two: Healthy diet More fruit and veg: The DASH, which emphasises fruit, vegetables, whole grains and lean proteins, has been shown to reduce blood pressure and improve heart health. Less fats: Too much saturated and trans fats can raise cholesterol levels and increase the risk of atherosclerosis. Go for healthier fats like those found in olive oil, nuts, and avocados. Limit salt: High salt intake is linked to high blood pressure, a major risk factor for both heart attack and stroke. The NHS recommends no more than 6g of salt per day for adults. Fibre: Foods high in soluble fibre, such as oats and beans, can help lower cholesterol levels. Exercise Walking, running, cycling, swimming - whatever you like, do it! Aerobic exercise can strengthen the heart and improve circulation. The NHS advises at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of vigorous-intensity activity each week. Strength training exercises can help control weight, improve cholesterol levels, and reduce blood pressure. It is recommended twice a week by the NHS. Manage blood pressure Healthy diet and exercise can help keep your blood pressure in check. But it is worth monitoring it yourself after the age of 40, at least, when the NHS invites adults for a check-up every five years. High blood pressure often has no symptoms but significantly increases the risk of heart attack and stroke. Quit smoking One of the best ways to quit smoking is to use resources provided by NHS Smokefree. Support groups, medications, and other tools to help quit smoking such as vapes could be what you need to kick the habit for good - and it's free. Limit booze Excessive alcohol consumption can increase blood pressure and contribute to weight gain, which can snowball and become a heart health risk. The NHS recommends not regularly drinking more than 14 units of alcohol per week.
BBC News
3 hours ago
- Health
- BBC News
NHS Devon scraps changes to cardiac care after objections
Planned trial changes to overnight heart attack services in south Devon have been Devon said it would not be going ahead with the proposals to drive out-of-hours heart attack patients to hospital in Exeter rather than Torbay to help cut costs and divert resources to cut treatment backlogs, said the Local Democracy Reporting signed a petition against the plan and two MPs said in the Commons the move could have endangered people. The service withdrew the plans in May to consider feedback and it now said it would develop a broader cardiology strategy for the region to be revealed next month. It said the strategy would be guided by clinical data and public feedback."Rather than only focusing on Percutaneous Coronary Intervention, the scope will be expanded to include prevention such as cardiovascular disease, urgent and emergency care and elective care," it said."The priority remains the commissioning of safe, reliable and sustainable cardiology services that meet the needs of Devon's population now and in the future." Steve Darling, Liberal Democrat MP for Torbay, said the U-turn was "very good news" and showed people "won't stand by when vital services are at risk"."It's not a definitive victory but it feels like a step in the right direction, now it all depends on where this journey ends," he said."By campaigning we have achieved the outcomes that many people wanted, and we can have higher levels of confidence that we know where we are heading."
South China Morning Post
9 hours ago
- South China Morning Post
Malaysian baby smothered to death by body of father, who died of heart attack
A family in Malaysia has suffered a heartbreaking double tragedy after a baby was smothered by his father, who had died in his sleep from a heart attack and rolled onto his child. Advertisement Three-month-old Muhammad Nur Daniel Nuruleffendy was pronounced dead by hospital officials in Melaka state, not long after he was brought in unconscious by his mother on Thursday morning. Azura Abdul Mallik, 40, found her third child on her bed with his face under her husband's right arm after coming back from her office at about 9.30am to take him for a check-up at a nearby clinic. Both Daniel and her husband, Nuruleffendy Ibrahim, 35, were unconscious but the baby was still breathing at the time. Nuruleffendy's sister, Masturadiana Ibrahim, said she learned of the incident only after Azura came to her house frantically asking for help. Advertisement 'She knocked repeatedly and called out my name saying: 'Help me, help me!',' Masturadiana, who lives opposite her brother and his family, told reporters at the Melaka general hospital.
Daily Mail
14 hours ago
- Health
- Daily Mail
Eddie Hearn reveals dad Barry suffered a heart attack during Leyton Orient play-off clash - before attending boxing fight just FIVE days later in rapid recovery
Barry Hearn suffered a heart attack last month during Leyton Orient's play-off semi-final clash against Stockport County, his son Eddie has revealed. Barry, a legendary sports promoter, who has been involved in snooker, boxing, darts, football and more, previously owned the Os between 1995 and 2014. And, according to Eddie, a renowned boxing promoter, Barry felt some discomfort during the first leg of play-off encounter against Stockport and had to be taken to hospital. The 77-year-old, who has had two previous heart attacks, then had a third stent installed. A stent is a small mesh-like tube that helps to keep arteries open and is a common procedure following a heart attack. Thankfully, Barry recovered and despite the ordeal, he was remarkably present at Dave Allen's boxing clash against Johnny Fisher just a week later. Reflecting on what happened, Eddie told Boxing Social: 'He's fine. Obviously it's always very scary, that kind of thing. It was at the Orient match. It will do that to you, Leyton Orient. 'Five minutes in and he said "I'll just see out the game". Unfortunately he had to go down to the doctors and get taken to hospital, he had a heart attack. 'He had another stent. He's had three stents now, three heart attacks. As far as he's concerned he's brand new now. He played cricket at the weekend for Essex Over-70s. He scored 60. 'It actually happened the weekend before the Johnny Fisher fight, so it was back in May, and he went to the Johnny Fisher fight, five days after the heart attack.' Speaking further about his father's rapid recovery and return to normality, Eddie provided further context. 'On the Monday he had a stent put in to his artery,' he added. 'Tuesday they let him out. So he gets back home Tuesday. 'So I'm like "right, well you won't be coming to the Johnny Fisher fight". He says "no I'm f***ing coming to the Johnny Fisher fight". 'No, what are you doing? "I'm not missing the Johnny Fisher fight!" I said "dad, chill out". He goes "I'm not living my life like that, I've had a new stent, I'm brand new".' Eddie continued: 'That's what you're dealing with. When he goes, my dad, it could be next week, or it could be in 10 years, you just never know when your time's up. The 77-year-old owned Orient, who play in League One, for 19 years from 1995 to 2014 'But you will be able to say he lived to the absolute max of his life. And that's a great thing to be able to say.' Orient went on to draw the first leg against Stockport 2-2 before they progressed to the final on penalties following a 1-1 draw in the second leg. However, the Os - who were owned by Hearn when they last reached the League One play-off final in 2014 when they lost to Rotherham - were beaten 1-0 by Charlton to consign Richie Wellens' side to another season in the third tier. Hearn had previously explained the painful nature of that dramatic defeat by Rotherham 11 years ago and how it had impacted him. 'I've been paying for therapy ever since that day against Rotherham!,' he said. 'I get nightmares about it. This (the Charlton game) is my opportunity to cleanse myself, take away my therapist bills, go back to normal sleep patterns.'
